12 employees
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
2014
$4.4M
from 1 investors over 1 rounds
Brenus Pharma raised $4.4M on March 17, 2022
Investors: Caisse d’Epargne